Answers are grounded in this paper and cite their sources.
Despite significant progress in the past 20 years, graft-versus-host disease (GVHD) remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). T-cell depletion (TCD) of the donor graft offers the potential for prevention of GVHD without
No takes yet. Share an insight, caveat, or question.
Ho et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: